New Data Intensifies Roche Drug Debate
Results of a 1,200 patient study by the National Eye Institute, a sector of the National Institutes of Health, suggest that macular medication Avastin, is as effective as its more expensive alternative Lucentis in treating blindness resulting from AMD.

http://ping.fm/BgwkH